...
首页> 外文期刊>Frontiers in Public Health >Bacterial Genome Wide Association Studies (bGWAS) and Transcriptomics Identifies Cryptic Antimicrobial Resistance Mechanisms in Acinetobacter baumannii
【24h】

Bacterial Genome Wide Association Studies (bGWAS) and Transcriptomics Identifies Cryptic Antimicrobial Resistance Mechanisms in Acinetobacter baumannii

机译:细菌基因组宽协会研究(BGWAs)和转录组织鉴定了肺杆菌的神秘抗微生物抗性机制

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Antimicrobial resistance (AMR) in the nosocomial pathogen, Acinetobacter baumannii , is becoming a serious public health threat. While some mechanisms of AMR have been reported, understanding novel mechanisms of resistance is critical for identifying emerging resistance. One of the first steps in identifying novel AMR mechanisms is performing genotype/phenotype association studies; however, performing these studies is complicated by the plastic nature of the A. baumannii pan-genome. In this study, we compared the antibiograms of 12 antimicrobials associated with multiple drug families for 84 A. baumannii isolates, many isolated in Arizona, USA. in silico screening of these genomes for known AMR mechanisms failed to identify clear correlations for most drugs. We then performed a bacterial genome wide association study (bGWAS) looking for associations between all possible 21-mers; this approach generally failed to identify mechanisms that explained the resistance phenotype. In order to decrease the genomic noise associated with population stratification, we compared four phylogenetically-related pairs of isolates with differing susceptibility profiles. RNA-Sequencing (RNA-Seq) was performed on paired isolates and differentially-expressed genes were identified. In these isolate pairs, five different potential mechanisms were identified, highlighting the difficulty of broad AMR surveillance in this species. To verify and validate differential expression, amplicon sequencing was performed. These results suggest that a diagnostic platform based on gene expression rather than genomics alone may be beneficial in certain surveillance efforts. The implementation of such advanced diagnostics coupled with increased AMR surveillance will potentially improve A. baumannii infection treatment and patient outcomes.
机译:抗微生物抗性(AMR)在医院病原体,鲍曼省的神经病原体,正成为严重的公共卫生威胁。虽然已经报道了一些AMR机制,但了解新颖的抵抗机制对于识别出现抗性至关重要。识别新型AMR机制的第一步之一正在进行基因型/表型协会研究;然而,通过A.Baumannii Pan-Genome的塑性性质,进行这些研究是复杂的。在这项研究中,我们比较了与84 A.Baumannii孤立,许多在亚利桑那州的多种药物家族相关的12个抗菌药物的抗菌药物。在硅筛选中,用于已知的AMR机制的这些基因组未能识别大多数药物的明显相关性。然后,我们进行了一种细菌基因组宽协会研究(BGWA)寻找所有可能的21兆的关联;这种方法通常未能识别解释阻力表型的机制。为了降低与人口分层相关的基因组噪声,我们将四个与不同的敏感性分布的4个与敏感性相对的分离物进行了比较。对成对分离株进行RNA测序(RNA-SEQ),并鉴定出差异表达的基因。在这些隔离对中,确定了五种不同的潜在机制,突出了该物种中广泛的AMR监测的难度。为了验证和验证差异表达,执行扩增子测序。这些结果表明,仅基于基因表达而不是基因组学单独的诊断平台可能是有益的。这种高级诊断的实施加上AMR监测增加将可能改善A.Baumannii感染治疗和患者结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号